Sarah Lawrence College

DigitalCommons@SarahLawrence
Human Genetics Theses

The Joan H. Marks Graduate Program in
Human Genetics

5-2018

An exploration of factors influencing patient outcomes of
psychiatric genetic counseling
Sarah Gerrard
Sarah Lawrence College

Angela Inglis
Sarah Lawrence College

Emily Morris
Sarah Lawrence College

Jehannine Austin
Sarah Lawrence College

Follow this and additional works at: https://digitalcommons.slc.edu/genetics_etd
Part of the Genetics Commons

Recommended Citation
Gerrard, Sarah; Inglis, Angela; Morris, Emily; and Austin, Jehannine, "An exploration of factors influencing
patient outcomes of psychiatric genetic counseling" (2018). Human Genetics Theses. 50.
https://digitalcommons.slc.edu/genetics_etd/50

This Thesis - Open Access is brought to you for free and open access by the The Joan H. Marks Graduate Program
in Human Genetics at DigitalCommons@SarahLawrence. It has been accepted for inclusion in Human Genetics
Theses by an authorized administrator of DigitalCommons@SarahLawrence. For more information, please contact
alester@sarahlawrence.edu.

An exploration of factors influencing patient outcomes of
psychiatric genetic counseling
Sarah Gerrard1, Angela Inglis2,3, Emily Morris2,3, Jehannine Austin2,3
1) Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College, Bronxville, NY
2) Department of Psychiatry, University of British Columbia, Vancouver, Canada
3) Department of Medical Genetics, University of British Columbia, Vancouver, Canada

Submitted in partial completion of the Master of Science Degree at Sarah
Lawrence College, May 2018

ABSTRACT
Though understanding how different characteristics of the patient and session influence outcomes of
genetic counseling (GC) is important, little research data currently exits on this topic. We conducted a
retrospective review of charts from patients who attended a specialist psychiatric GC clinic between
February 1, 2012 and January 31, 2017. We extracted data to explore the effects of patient and sessionrelated variables on Genetic Counseling Outcome Scale scores (GCOS, validated instrument that
measures empowerment). We used ANOVA to analyze the pre-, to one-month post-GC change in GCOS
scores in relation to eleven variables. 307 charts were included in analysis. Overall, GCOS scores
significantly increased after GC (p<0.0005). No significant differences in GCOS change scores were
identified with respect to: sex, ethnicity, diagnosis, mode of referral, type of appointment, genetic
counseling student involvement, presence of observers or personal/family history of mental illness.
Significant relationships were found between GCOS change scores and mode of delivery of GC (p=0.048,
h2 = 0.020) and primary indication for the appointment (understanding recurrence risk versus other,
p=0.001, h2 = 0.037). This exploratory study provides the first data on how a number of characteristics
of the patient and session influence outcomes of genetic counseling. Understanding the patient and
session-related factors that do seem to influence outcomes may allow for adjustment of service delivery
strategies to promote the best possible outcomes.
Key Words
Genetic counseling, empowerment, Genetic Counseling Outcome Scale, patient outcomes, patient
variables, session variables

INTRODUCTION
It has become increasingly important for the genetic counseling profession to demonstrate the value of
genetic counseling through research evaluating patient outcomes. The National Society of Genetic
Counselors (NSGC) has prioritized the identification of outcomes unique to genetic counseling, for use
in outcome research and clinical intervention (Redlinger-Grosse et al., 2016). Since outcomes in the
field of genetic counseling have yet to be well defined, a recent study aimed to elucidate and categorize
outcomes defined by diverse groups of practicing genetic counselors (Zierhut, Shannon, Cragun, &
Cohen, 2016). The most common outcome themes involved appropriate ordering of genetic tests and
accurate interpretation of results, adherence to appropriate medical management, psychosocial
outcomes and patient and provider knowledge (Zierhut et al., 2016). An additional unique outcome
identified was the impact of genetic counseling on family member outcomes (Zierhut et al., 2016).

Important patient related outcomes such as satisfaction, knowledge and empowerment have been
identified and validated through a growing body of studies. The majority of genetic counseling outcome
studies have focused on cancer genetic counseling (Burke et al., 2000; Cabrera, Blanco, Yagüe, &
Zabalegui, 2010; Cragun et al., 2015; Oberguggenberger et al., 2016). These studies demonstrated that
after genetic counseling patients had more accurate perceptions of cancer risk, they were more
knowledgeable about cancer and were less anxious about their personal cancer risk (Burke et al., 2000;
Cabrera et al., 2010). Additional research to date indicates that genetic counseling increases the level of
patient knowledge and positive health behaviors, while decreasing anxiety and decisional conflict
(Madlensky et al., 2017). There is increasing evidence that the most important outcomes of genetic
counseling are psychosocial, which is in accordance to a psychotherapeutically oriented approach in
this field, and demonstrates the validity of these outcome measures (Austin, Semaka, & Hadjipavlou,
2015). Empowerment has been identified as a patient benefit from clinical genetic services, and can be
defined as a set of beliefs that enable an individual to feel that they have some control over and hope for
the future (Marion Mcallister, Dunn, & Todd, 2011).

In addition to the lack of research evaluating patient outcomes, limited research has analyzed the
effects of patient or session-related variables on genetic counseling outcomes. Several studies have
addressed potential differences between modes of genetic counseling; specifically telephone genetic
counseling versus traditional in-person genetic counseling. A randomized non-inferiority trial
comparing pre- and post-test telephone BRCA1/2 genetic counseling to standard in-person genetic
counseling showed no significant differences between knowledge, satisfaction, decision conflict and
cancer distress two-weeks and three-months post genetic counseling (Schwartz et al., 2014). There isn’t
sufficient evidence to support the telephone genetic counseling model as a comparative alterative to inperson counseling with respect to all patient outcomes. However, research does indicate many positive
and comparable outcomes. A recent study demonstrated that method of obtaining family history
information had a significant impact on patient-reported self-efficacy (Slomp, Morris, Inglis, Lehman, &
Austin, 2017). Specifically, there was a significant increase in IMSES scores, one-month after genetic
counseling, for individuals who had their family history taken before their appointment, and a nonsignificant decrease in IMSES scores, one-month post genetic counseling, for individuals who had their
family history taken during the appointment (Slomp et al., 2017). The IMSES is an instrument that
measures confidence in managing psychiatric illness (Slomp et al., 2017).

While the effects of referral type have not been researched in the context of a genetic counseling
appointment, some preliminary studies suggest a difference in outcomes between individuals who selfrefer and those who are referred by a health care provider in clinical genetics and healthcare services
(Christensen et al., 2015; Snyder et al., 2008). In a study examining the behavioral impact of genetic risk
information for Alzheimer’s disease, self-referred participants were more likely than actively recruited
participants to make behavioral changes, such as changes in mental activities and diet, based on their
genetic risk assessment results (Christensen et al., 2015). In another study, cancer survivors who selfreferred to a study testing the efficacy of diet and exercise interventions had greater increases in

weekly exercise minutes and fruit and vegetable consumption compared to those who were referred,
and displayed greater motivation to respond to educational materials (Snyder et al., 2008).
Investigating the potential differences between self-referrals and referrals from a health care provider
to genetic counseling services, and their relationship with outcome measures, may provide insight into
future modes of referral for genetic counselors.

In a first-year evaluation of a specialized psychiatric genetic counseling clinic in Vancouver, BC there
were significant increases shown, one-month post genetic counseling, in the baseline levels of
empowerment (p<0.0001) and self-efficacy (p=0.011) (Inglis, Koehn, Mcgillivray, Stewart, & Austin,
2015). There is little research evaluating the impact of different patient and session variables on levels
of empowerment, and limited research on other outcomes. While some research has evaluated modes
of genetic counseling service delivery and method of family history taking, no research has examined
the effects of other variables such as sex, ethnicity, diagnosis, modes of referral, primary indication for
referral, type of appointment, genetic counseling student involvement, presence of observers, special
group designation, and personal and family histories of mental illness on patient outcomes of genetic
counseling. We aim to perform an exploratory story that examines the change (from before, to onemonth post genetic counseling) in levels of empowerment with respect to several variables.
Understanding factors that influence outcome measures may allow for adjustment of service delivery
strategies to promote the best possible outcomes for different types of patients attending genetic
counseling sessions.

MATERIALS AND METHODS
Participants and Procedure
We conducted a retrospective chart review using data from patients who received genetic
counseling at a specialist psychiatric genetic counseling clinic in Vancouver, BC, between February 1,
2012 and January 31, 2017, and were entered into a clinical database. Typically, all English-speaking

patients who attend this clinic complete the Genetic Counseling Outcome Scale (GCOS) prior to
genetic counseling (T1) and again at the standard one-month follow-up time point (T2). This clinical
instrument is used at T1, along with the Illness Management Self Efficacy Scale (ISMES) for patients
with a personal lived experience of mental illness, to assist the genetic counselor in establishing
pertinent discussion points for the session. At T2, these clinical instruments aid in assessing how the
patient is doing and what additional topics may need to be addressed. We did not assess ISMES
scores in this study. For a further description on the psychiatric genetic counseling clinic see Inglis et
al., 2014. The following patient data, stored in a de-identified clinical database includes, but is not
limited to: demographic information, diagnosis, mode of referral (self-referral or referral from a
health care provider), mode of genetic counseling (in-person, telephone or telehealth), primary
indication for referral, type of appointment (family or individual), genetic counseling student
involvement (yes or no), presence of observers (yes or no), special group designation (referrals from
BC Children’s Hospital OCD clinic, referrals for inpatients at Burnaby Centre for Mental Health and
Addictions, or no special group designation), personal and family histories of mental illness and
GCOS scores. We extracted patient data that met the following criteria: (1) they attended their first
appointment between February 1, 2012 and January 31, 2017, (2) the patient was the primary
individual attending the appointment, and (3) the patient had completed the GCOS prior to (T1) and
one-month post (T2) genetic counseling. The primary individual attending the appointment is
defined as the original patient referred, and not a family member or additional individual attending
the appointment. Institutional Review Board approval was received from the BC Children and
Woman’s Research Ethics Board (H15-02632).

Quantitative Instrument
The GCOS is a validated, clinical genetics-specific PROM (patient reported outcome measure) (M.
Mcallister, Wood, Dunn, Shiloh, & Todd, 2011). This instrument measures levels of empowerment,
incorporating components such as perceived personal control, emotional regulation, benefits to

other relatives, and hope for the future (M. Mcallister et al., 2011). All 24 items are rated on a 7-point
Likert scale (1= strongly disagree, 7 = strongly agree). Scores range from 24 to 168 with higher
scores indicating higher levels of empowerment. All patients attending the psychiatric genetic
counseling clinic, including those with personal and/or family histories of mental illness, completed
the GCOS whenever it was appropriate. Instances where patients would not complete the GCOS at
one or both of the time points would include when: (1) the patient is actively experiencing
symptoms of psychosis, (2) time constraints of appointment, or (3) the patient declines.

Data Analyses
Descriptive statistics were applied to the demographic data, and GCOS total scores at T1 and T2 were
calculated according to instrument-specific instructions. In accordance to these, any patients who
declined to answer 6 or more questions on the instrument were removed from analysis. We
conducted a paired sample t test to compare the overall change in GCOS scores from T1 to T2. We
used a significance threshold of p<0.05. Next, we conducted one-way between-group analyses of
variance (ANOVAs) for each variable using mean GCOS change scores (T2 – T1), and a significance
threshold of p<0.05. We excluded any group where the sample size was equal to one, due to
constraints of the analysis parameters. For the special groups designation variable, there were 5
patients categorized as 22q11.2 referrals who were excluded since they will be assessed in another
study. For this variable, we conducted separate ANOVAs comparing referrals from BC Children’s
Hospital OCD clinic to patients with no special group designation, and referrals from inpatients at
Burnaby Centre for Mental Health and Addictions to patients with no special group designation. For
two variables, primary indication for referral and personal history of mental illness, patients in the
clinical database were present in more than one group. For this reason, an ANOVA was conducted
separately for each group within the primary indication for referral variable. A composite variable
was created for the personal history of mental illness variable, and we conducted an ANOVA for
individuals with a personal history of schizophrenia, bipolar disorder or schizoaffective disorder.

Any additional diagnoses were described. Assumptions for continuity, independence of
observations, and normality were met. The homogeneity of variance assumption was met for all
variables except the Burnaby Centre referrals group in the special group designation variable. For
that analysis, we used a Welch test instead of ANOVA, and a significance threshold of p<0.05. For
variables with a significant ANOVA (p<0.05), we performed the Tukey’s HSD post hoc analysis, with
a significance threshold of p<0.05. These analyses were performed using IBM SPSS Statistics 24.

RESULTS
There were 318 patients in the clinical database that met the inclusion criteria. Of those, 307 had no
more than 5 unanswered items in the GCOS instrument at either T1 or T2 time points. The average
age of patients analyzed were 41 years old, the majority were female (83.4%), and the most common
ethnicity was European (67.8%). Comprehensive demographic data is shown in Table 1.
Table 1 Demographic information

Age [mean(sd)]
Sex [n (%)]

All patients (included in analysis)
N = 307
41.13 (12.09)
Male
Female
Other

50 (16.3)
256 (83.4)
1 (0.3)

European
Asian
Aboriginal
African
Mixed
Other
Unknown
Personal History of Mental Illness [n]1
Schizophrenia
Bipolar disorder
Schizoaffective
OCD
Depression
Anxiety
Eating disorder
ADD/ADHD
Autism/ASD
PTSD
Borderline Personality disorder
Addiction

208 (67.8)
46 (15.0)
1 (0.3)
3 (1)
34 (11.1)
3 (1)
12 (3.9)

Ethnicity [n (%)]

17
55
6
12
168
118
13
11
1
21
6
28

Other
Family History Only
1Patients may have more than one diagnosis

19
48

Table 2 Assessment of GCOS scores using paired sample t tests

GCOS T1 scores [mean (sd)]
GCOS T2 scores [mean (sd)]
Change (T2-T1) [mean (sd)]
p value
Cohen’s d

All patients (included in analysis)
N = 307
111.09 (17.68)
127.17 (18.20)
16.08 (14.63)
<0.0005
1.10

Overall, GCOS scores significantly increased from T1 to T2 (p<0.0005, d=1.10) (see Table 2). There
was no significant difference in GCOS change scores (T2 – T1) for individuals of different sex (F (1,
304) = 2.158, p=0.143) or ethnicity (F (4, 289 = 0.727), p=0.574). There were no significant
differences in GCOS change scores with respect to: mode of referral (F (1, 305) = 1.266, p=0.261),
types of appointment (F (1, 305) = 0.326, p=0.568), genetic counseling student involvement (F (1,
299) = 0.036, p=0.851) or presence of observers (F (1, 167 = 0.061, p=0.805). Additionally, there
were no significant differences in GCOS change scores comparing referrals from BC Children’s
hospital OCD clinic patient to referrals with no special group designation (F (1, 289) = 0.099,
p=0.754), or comparing referrals from Burnaby Centre for Mental Health and Addictions to referrals
with no special group designation (Welch’s F (1, 10.328) = 2.553, p=0.140).

A significant relationship was found between GCOS change scores and mode of genetic counseling (F
(2, 304) = 3.067, p=0.048). The effect size was small (h2 = 0.020), and Tukey’s post hoc analysis
identified no significant differences between groups. There was a quantitative increase in GCOS
change scores from the telephone genetic counseling group (M = 12.49, SD = 13.35) to the in-person
counseling group (M = 17.11, SD = 14.84), a mean increase of 4.62, SE = 2.29, which was not
statistically significant (p=0.111). There was also a quantitative increase in GCOS change scores from
the telehealth genetic counseling group (M = 10.80, SD = 12.90) to the in-person genetic counseling

group (M = 17.11, SD = 14.84), a mean increase of 6.31, SE = 3.87, but it was not statistically
significant (p=0.234). There was a significant increase in GCOS change scores for patients who stated
that recurrence risk was a primary indication for referral, compared to those who did not (F (1, 305)
= 11.624, p=0.001). The effect size was small to medium (h2 = 0.037). There were no significant
differences in GCOS change scores for patients who stated other primary indications, including:
understanding causes of mental illness (F (1, 305) = 1.149, p=0.285), information regarding
protective factors (F (1, 305) = 0.618, p=0.411), previous genetic testing (1, 305) = 0.005, p=0.942),
pregnancy related (F (1, 305) = 0.925, p=0.337), other primary indications (F (1, 305) = 2.034,
p=0.155, or unsure about primary indication (F (1, 305) = 3.368, p=0.067), compared to those who
didn’t. There were no significant differences in GCOS change scores comparing individuals with a
personal history of mental illness, to those with a family history only (F (1, 305) = 1.233, p=0.268).
Finally, there was no significant difference in GCOS change scores between individuals with a
diagnosis of schizophrenia, bipolar disorder or schizoaffective disorder (F (2, 77) = 2.422, p=0.096).
Table 3 Comparison of GCOS change scores using a one-way between groups ANOVA
n

T1 mean (sd)

T2 mean (sd)

Change (sd)
(T2-T1)

ANOVA
p value

h2

Male
Female
Other

50
256
1

111.65 (17.15)
110.93 (17.82)
124.00

125.05 (19.50)
127.63 (17.97)
114.78

13.40 (17.26)
16.70 (13.97)
-9.22

0.1432

0.007

European
Asian
Aboriginal
African
Mixed
Other
Mode of referral
Self-referral
Health care provider
Mode of GC
Telephone
In-person
Telehealth
Primary Indication
Recurrence risk
Understanding causes
Protective factors
Had genetic testing

208
46
1
3
34
3

111.38 (17.42)
113.48 (15.73)
111.00
95.29 (17.28)
107.22 (22.22)
108.57 (25.75)

128.30 (17.69)
126.93 (17.83)
110.00
111.29 (29.65)
124.46 (17.18)
118.49 (43.85)

16.92 (14.60)
13.45 (14.05)
-1.00
16.00 (12.62)
17.23 (13.56)
9.93 (19.13)

0.5742

0.010

114
193

109.62 (16.38)
111.96 (18.38)

124.48 (18.12)
128.76 (18.11)

14.86 (15.61)
16.80 (14.01)

0.261

0.004

48
244
15

111.08 (19.54)
110.89 (17.22)
114.37 (19.64)

123.57 (18.47)
128.00 (18.13)
125.17 (18.15)

12.49 (13.35)
17.11 (14.84)
10.80 (12.90)

0.048

0.020

147
189
81
4

110.87 (17.56)
110.47 (17.80)
114.76 (16.98)
93.39 (18.03)

129.87 (16.04)
127.26 (18.58)
129.69 (18.11)
110.00 (23.76)

19.00 (13.83)
16.79 (14.72)
14.93 (12.52)
16.61 (17.17)

0.001
0.285
0.411
0.942

0.037
0.004
0.002
0.000

Sex

Ethnicity

Pregnancy related
Other
Unsure
Type of appointment
Family
Individual
GC student involvement
Yes
No
Presence of observer
Yes
No
Special Groups
OCD clinic
Burnaby Centre
None
History of Mental Illness
Personal History
Family History Only

17
6
20

121.74 (15.41)
98.00 (10.55)
117.19 (13.98)

134.50 (15.50)
122.50 (13.03)
127.49 (21.56)

12.76 (9.37)
24.50 (10.03)
10.30 (17.84)

0.337
0.155
0.067

0.003
0.007
0.011

89
218

110.72 (16.16)
111.24 (18.29)

127.54 (16.63)
127.02 (18.84)

16.83 (15.60)
15.78 (14.24)

0.568

0.001

72
229

112.45 (17.23)
110.59 (17.70)

128.51 (20.62)
127.03 (17.23)

16.06 (13.45)
16.44 (14.99)

0.851

0.000

38
131

116.31 (15.20)
111.51 (17.92)

132.45 (17.18)
127.04 (18.11)

16.13 (11.82)
15.53 (13.75)

0.805

0.000

16
11
275

118.22 (19.93)
116.68 (16.82)
110.20 (17.48)

133.63 (16.95)
122.25 (25.45)
126.76 (18.00)

15.41 (9.92)
5.57 (22.62)
16.56 (14.44)

0.754
0.1403

0.000
-

259
48

111.16 (18.10)
110.73 (18.10)

127.64 (18.35)
124.66 (18.35)

16.48 (14.61)
13.93 (14.72)

0.268

0.004

0.096

0.061

Personal History
Schizophrenia1 17
114.65 (16.78) 123.85 (21.82)
9.20 (18.15)
Bipolar disorder1 55
112.03 (20.38) 129.04 (18.19) 17.01 (16.00)
Schizoaffective1
6
118.49 (14.61) 123.17 (30.94)
4.68 (23.18)
1Includes all individuals regardless of an additional diagnosis
2Excluded groups where n=1 for the purposes of this analysis
3Welch analysis performed (homogeneity of variance assumption not met)

DISCUSSION
In order to assess the effectiveness of genetic counseling it is important to identify and measure specific
outcomes. While there is prior research focusing on these two goals, and limited research assessing the
effect of variables on outcomes, this is the first study to examine the influence of multiple patient and
session-related variables on outcomes in genetic counseling. Overall, there was a significant increase in
empowerment following genetic counseling (p<0.0005). This result was expected based on previous
research (Inglis et al., 2015; Slomp et al., 2017). The patient variables sex and ethnicity had no impact
on levels of empowerment. This finding demonstrates that patients with different sexes and ethnicities
benefit from psychiatric genetic counseling. While the patient variable sex captures sex assigned at
birth, we didn’t assess the gender identity of each patient which would capture an assessment of gender
experience and outcomes in genetic counseling. There was one patient, who met inclusion criteria, who

identified as transgender however we had to exclude them when performing the ANOVA due to
constraints of the analysis parameters.

Four additional variables assessed had no impact on levels of empowerment: mode of referral (selfreferral or referral from a health care provider), type of appointment (individual or family), genetic
counseling student involvement (yes or no) and presence of observers (yes or no). It’s possible that
smaller differences in levels of empowerment between these groups were masked by large increases in
levels of empowerment for all patients. While the GCOS change scores were quantitatively larger for
those who were referred by health care provider, it was not statistically significant. This quantitative
difference could be explained by the hypothesis that individuals who self-refer have higher baseline
levels of empowerment, however the T1 GCOS scores were not significantly different between the two
groups (t (305) = -1.119, p=0.264). Individuals who self-refer may have stronger personal or family
histories of disease, higher levels of anxiety, or other psychosocial variables that may play a role in their
response to treatment (Audrain et al., 1998; Henrikson, Harris, & Bowen, 2007). In order to better
elucidate these contributing factors, it would be important to further evaluate these two groups
regarding their main concerns and personal or family histories of mental illness. The mode of referral
may have no impact on genetic counseling outcomes, however these results raise the importance of
educating health care providers about the benefits and outcomes of psychiatric genetic counseling. The
referring health care providers involved in this study included psychiatrists, general practitioners,
genetic counselors and mental health workers. Patients experienced increased levels of empowerment,
regardless of additional individuals attending the appointment, including other family members,
genetic counseling students who participate in the session and observers who don’t participate. In fact,
the effect sizes are remarkably low (h2 < 0.001). This demonstrates that the effects of genetic
counseling, for primary patients, are not affected by additional attendees such as their children, parents,
or spouses. It was not expected that the presence of genetic counseling students or silent observers
would impact the effects of psychiatric genetic counseling. No significantly different effect of genetic

counseling with respect to special group designation was detected. Importantly, patients referred from
the Burnaby Centre had quantitatively lower GCOS change scores (M = 5.57, SD = 22.62) compared to
patients who weren’t referred from a special group (M = 16.56, SD = 14.44), however the differing
sample sizes in these two groups and non-homogeneity of variance did not allow for elucidation of this
finding. This warrants further investigation.

The mode of genetic counseling did have a significant impact on the patient-reported measure of
empowerment (p=0.048). While Tukey’s post hoc analysis was not significant, patients who received inperson genetic counseling had quantitatively larger GCOS change scores compared to patients who
received genetic counseling over the phone, or through videoconference. Only 48 patients received
telephone genetic counseling, and 15 patients were seen through telehealth, compared to 244 patients
who came in-person to their genetic counseling appointment. The trend demonstrated is larger
increases in empowerment, after genetic counseling, for individuals who receive in-person genetic
counseling, and equivalent samples sizes would lend support to this observation. A randomized trial
comparing telegenetics to in-person cancer genetic counseling reported patient satisfaction did not
differ by group on either satisfaction scale, but also identified the need for further randomized trials to
compare longer-term psychosocial and behavioral outcomes (Buchanan et al., 2015). Telephone genetic
counseling has the potential to increase access to comprehensive genetic services and decrease costs,
however the concerns arise when considering the ability to translate knowledge and provide adequate
patient support (Schwartz et al., 2014). It’s important to assess alternative delivery modes, and their
relationship with patient outcomes, given the increased demand for genetic counseling and genetic
testing. Although previous literature has demonstrated comparable outcome between in-person genetic
counseling and telephone genetic counseling, these results suggest that patients benefit from in-person
genetic counseling, with respect to levels of empowerment.

Primary indications for referral impacted genetic counseling outcomes, although these results are
interpreted with caution. There was a significant increase in levels of empowerment for patients who
stated that understanding recurrence risk was a primary indication for referral, compared to patients
who did not (p=0.001). The effect size was small to medium (h2 = 0.037), indicating that increases in
levels of empowerment can be moderately attributed to that primary indication. The effects of genetic
counseling may be greater when patients are interested in understanding the recurrence risk estimates,
related to mental health conditions, for themselves or their family members. However, some patients
within the understanding recurrence risk group stated additional primary indications for referral that
could be confounding these results. Our approach to this analysis is an appropriate first step, but more
in-depth investigation will better elucidate how patients with different primary concerns benefit from
genetic counseling. No effect on levels of empowerment were found when assessing the other primary
indications individually, including: understanding the causes of mental illness, information regarding
protective factors, the presence of previous genetic testing, pregnancy related factors, other indications
and patients who were unsure of their primary indication.

History of mental illness had no impact on levels of empowerment when comparing individuals with a
personal history of mental illness to individuals with a family history of mental illness only.
Additionally, there were no significant differences in levels of empowerment when comparing
individuals with a personal history of schizophrenia, bipolar disorder or schizoaffective disorder.
Previous research has demonstrated that genetic counseling improves knowledge and risk perception
accuracy for individuals with these serious mental illnesses (Hippman et al., 2016). Therefore, we chose
to expand on this and assess the impact of these specific diagnoses on levels of empowerment after
genetic counseling. Our results demonstrate that individuals with different diagnoses of a serious
mental illness benefit from genetic counseling. Individuals were included in this analysis regardless of
additional diagnoses (anxiety, depression or others).

Study limitations
This exploratory study was conducted using a convenience sample, and therefore there was no
control group. All client data was accessed retrospectively, and all patients included received genetic
counseling. Additional limitations include the patient demographics. The majority of patients were
female, European and had a personal history of mental illness (Personal history n = 259, Family
history only n = 48). The psychiatric diagnoses were per patient report, and not confirmed.
Furthermore, GCOS scores were measured one-month after genetic counseling, but longer-term
effects were not assessed. While this study was conducted in a specialist clinic, we predict that these
results translate to all areas of the genetic counseling profession although validation is warranted.

Practice implications
These findings highlight the importance of educating genetic counselors about specific patient
outcomes, and indicates a need to delineate the influence that patient and session-related variables
have on outcomes in genetic counseling. Evaluating outcomes in clinical genetics has been difficult
because traditional measures of health status are not applicable in chronic genetic conditions (M.
Mcallister et al., 2011). This study utilizes the validated GCOS-24, that captures the construct of
empowerment as an outcome of genetic counseling. GCOS-24 includes aspects of perceived personal
control, which is considered a valid outcome measure for genetic counseling and extends beyond
traditionally accepted educational outcomes (Berkenstadt, Shiloh, Barkai, Katznelson, & Goldman,
1999). It also captures emotional regulation and hope for the future, which has not been included in
previous questionnaires (M. Mcallister et al., 2011). Our data demonstrates that patients with
different ethnicities, sexes and diagnoses benefit from psychiatric genetic counseling, and that
patient and session-related variables do seem to influence genetic counseling outcomes. As an
exploratory study these findings provide an initial framework for future studies to expand on, and
highlight the implications that evidence based research may have on genetic counseling practice.

Research recommendations
This research lends support to future areas of research, including other factors that may influence
patient outcomes such as coping style. In studies analyzing the effect of coping style on emotional
outcomes after testing and cancer genetic counseling, researchers found that individuals with a “high
monitoring” coping style have a greater desire for information regarding their illness and may have a
higher need for certainty with respect to test results (Nordin, K., Liden, A., Hansson, M., Rosenquist, R.,
Berglund, 2002; Shiloh, S., Koehly, L., Jenkins, J., Martin, J., Hadley, 2008). One common genetic
counseling outcome theme identified by Zierhut et al., 2016 was adherence to medical management,
which could be explored in future research assessing adherence to medication, or the number of
presentations to clinics or hospitals. It is important to acknowledge that themes involving genetic
testing and adherence to appropriate medical management are not common in genetic counseling
outcome literature, while psychosocial outcomes and levels of knowledge are very commonly
discussed. This could represent changes in the field, such as an increasing number of variants of
uncertain significance (VUS), as we are implementing testing ahead of our ability to explain all genetic
variation. Additionally, there are limited studies looking at long-term health outcomes, and the diverse
practice settings in which genetic counselors work (Madlensky et al., 2017). An additional outcome, that
we were unable to assess in this study, was the impact of genetic counseling on family members. Future
research could assess levels of empowerment for family members of primary patients, as measured by
the GCOS. Furthermore, we did not assess family history of mental illness with respect to different
diagnoses. Finally, the primary indications for referral variable can be divided further to compare
whether this concern is related to the patient themselves, or to others.

CONCLUSION
This exploratory study provides the first data on how a number of characteristics of the patient and
session influence outcomes of genetic counseling. Patients benefit from psychiatric genetic counseling,
regardless of sex, ethnicity, diagnosis, history of mental illness, students, observers and additional

attendees. We demonstrate that in-person genetic counseling may lead to greater outcomes for
patients, and that variables such as the primary indications for referral, specifically understanding
recurrence risk, may predict different outcomes of genetic counseling for patients. Furthermore, it adds
continued support to the value in psychiatric genetic counseling for individuals with a personal or
family history of mental illness. There is a need for more evidence based research evaluating patient
outcomes in genetic counseling, which is useful in order to better understand how current services
meet patient’s needs, and which changes in service delivery will be the most effective.
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